228 related articles for article (PubMed ID: 34856971)
1. Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study.
Feng CM; Wang XM; Li MD; Xu Z; Hua DX; Cheng JY; Zheng L; Zhao H; Fu L
BMC Pulm Med; 2021 Dec; 21(1):393. PubMed ID: 34856971
[TBL] [Abstract][Full Text] [Related]
2. Serum IL-27 predicts the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Xu Z; Wang XM; Cao P; Zhang C; Feng CM; Zheng L; Xu DX; Fu L; Zhao H
Int J Med Sci; 2022; 19(1):74-81. PubMed ID: 34975300
[No Abstract] [Full Text] [Related]
3. Serum 8-Hydroxydeoxyguanosine Is a Potential Indicator for the Severity and Prognosis in Patients with Community-Acquired Pneumonia: A Prospective Cohort Study.
Cao LF; Cheng JY; Xu Z; Feng CM; Zhao H; Wang XM; Fu L
J Immunol; 2022 Jan; 208(2):321-327. PubMed ID: 34911771
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal associations between serum IL-34 with severity and prognosis in community-acquired pneumonia patients.
Tang F; Hou XF; Cheng Y; Liu Y; Sun J; Liu HY; Lv LP; Fu L
Respir Investig; 2024 Mar; 62(2):223-230. PubMed ID: 38218098
[TBL] [Abstract][Full Text] [Related]
5. Serum SOD1 level predicts the severity and prognosis of community-acquired pneumonia patients.
Xie GF; Cheng JY; Liu Y; Sun J; Hua DX; He QY; Yang J; Zhao H; Lu YJ; Fu L
Am J Med Sci; 2024 May; ():. PubMed ID: 38825074
[TBL] [Abstract][Full Text] [Related]
6. Serum TRAIL predicts severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Hua DX; Ma KS; Cheng JY; Liu Y; Sun J; He QY; Deng YP; Yang J; Fu L; Zhao H
Intern Emerg Med; 2022 Nov; 17(8):2279-2290. PubMed ID: 36241932
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal associations of serum survivin with the severity and prognosis of community-acquired pneumonia patients.
Cheng JY; Tang MM; Fang P; Liu Y; Sun J; He QY; Deng YP; Hou XF; Zhao H; Fu L
Respir Investig; 2023 Jan; 61(1):84-94. PubMed ID: 36336629
[TBL] [Abstract][Full Text] [Related]
8. The Associations of Serum IL-37 With the Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Retrospective Cohort Study.
Wang JL; Chen X; Xu Y; Chen YX; Wang J; Liu YL; Song HT; Fei J; Zhao H; Fu L
Front Immunol; 2021; 12():636896. PubMed ID: 34025645
[TBL] [Abstract][Full Text] [Related]
9. Associations of Serum S100A12 With Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Prospective Cohort Study.
Jiang X; Huang CM; Feng CM; Xu Z; Fu L; Wang XM
Front Immunol; 2021; 12():714026. PubMed ID: 34745092
[TBL] [Abstract][Full Text] [Related]
10. The associations of serum S100A9 with the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Liu HY; Xiang HX; Xiang Y; Xu Z; Feng CM; Fei J; Fu L; Zhao H
BMC Infect Dis; 2021 Apr; 21(1):327. PubMed ID: 33827454
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional and longitudinal associations of serum Cysteine-rich 61 with severity and prognosis among community-acquired pneumonia patients in China.
Yao MX; Cheng JY; Liu Y; Sun J; Hua DX; He QY; Liu HY; Fu L; Zhao H
Front Med (Lausanne); 2022; 9():939002. PubMed ID: 36035395
[TBL] [Abstract][Full Text] [Related]
12. Cold-inducible RNA-binding protein might determine the severity and the presences of major/minor criteria for severe community-acquired pneumonia and best predicted mortality.
Guo Q; Song WD; Li HY; Li M; Chen XK; Liu H; Peng HL; Yu HQ; Liu N; Lü ZD; Liang LH; Zhao QZ; Jiang M
Respir Res; 2020 Jul; 21(1):192. PubMed ID: 32689999
[TBL] [Abstract][Full Text] [Related]
13. Serum Level of 4-Hydroxynonenal in Community-Acquired Pneumonia: A Potential Biomarker for Severity and Prognosis.
Jiang YL; Liu HY; Tang MM; Cheng JY; Zhao H; Fu L
Front Med (Lausanne); 2022; 9():798343. PubMed ID: 35783645
[TBL] [Abstract][Full Text] [Related]
14. Associations of Serum Resistin With the Severity and Prognosis in Patients With Community-Acquired Pneumonia.
Feng CM; Cheng JY; Xu Z; Liu HY; Xu DX; Fu L; Zhao H
Front Immunol; 2021; 12():703515. PubMed ID: 34858392
[TBL] [Abstract][Full Text] [Related]
15. D-dimer as A Biomarker of Severity and Adverse Outcomes in Patients with Community Acquired Pneumonia.
Cerda-Mancillas MC; Santiago-Germán D; Andrade-Bravo B; Pedraza-Olivares F; Valenzo-Hernández F; Leaños-Miranda A; Isordia-Salas I
Arch Med Res; 2020 Jul; 51(5):429-435. PubMed ID: 32402575
[TBL] [Abstract][Full Text] [Related]
16. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity.
Wu HP; Chen CK; Chung K; Jiang BY; Yu TJ; Chuang DY
J Formos Med Assoc; 2009 Jan; 108(1):20-7. PubMed ID: 19181604
[TBL] [Abstract][Full Text] [Related]
17. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
Antunes G; Evans SA; Lordan JL; Frew AJ
Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
[TBL] [Abstract][Full Text] [Related]
18. Elevated Red Blood Cell Distribution Width Combined White Blood Cell in Peripheral Blood Routine Have a Better Sensitivity than CURB-65 Scores in Predicting ICU Admission and Mortality in Adult Community-Acquired Pneumonia Patients.
Ge YL; Liu CH; Rana MA; Zhu XY; Wang N; Xu J; Su CS; Li HL; Li ZZ; Hassan RA; Li HL; Zhang HF; Zhang X; Yu HL; Zhang JB; Fu AS; Wang HY
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868855
[TBL] [Abstract][Full Text] [Related]
19. Admission Pentraxin-3 Level Predicts Severity of Community-Acquired Pneumonia Independently of Etiology.
Luo Q; He X; Ning P; Zheng Y; Yang D; Xu Y; Shang Y; Gao Z
Proteomics Clin Appl; 2019 Jul; 13(4):e1800117. PubMed ID: 30557448
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia.
Viasus D; Garcia-Vidal C; Simonetti A; Manresa F; Dorca J; Gudiol F; Carratalà J
J Infect; 2013 May; 66(5):415-23. PubMed ID: 23286966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]